Advances in surgery-related adjuvant therapy of intrahepatic cholangiocarcinoma

VernacularTitle: 肝内胆管细胞癌手术相关辅助治疗的进展
Author: Jiyao SHENG ^{1
,

2} ; Xuewen ZHANG ^{1
,

2}
Author Information

1. Department of Hepatobiliary and Pancreatic Surgery, the Second Hospital of Jilin University
2. Jilin Engineering Laboratory for Translational Medicine of Hepatobiliary and Pancreatic Diseases, Changchun130041, China
Publication Type:Journal Article
Keywords: Biliary duct neoplasms; Surgical procedures, operative; Neoadjuvant therapy; Intrahepatic cholangiocarcinoma
From: International Journal of Surgery 2020;47(2):73-77
CountryChina
Language:Chinese
Abstract: Intrahepatic cholangiocarcinoma (ICC) has a poor prognosis. Surgical treatment combined with adjuvant therapy including chemotherapy, radiotherapy, molecular targeted drug therapy, local liver damage therapy, interventional therapy, antiviral therapy can have complementary effects to prevent its recurrence after surgery. We will review the latest advances in surgery and adjuvant therapy for ICC, and provide new ideas for the comprehensive treatment and clinical research of ICC.